Behnaz Lahooti

641 total citations
11 papers, 470 citations indexed

About

Behnaz Lahooti is a scholar working on Molecular Biology, Biomaterials and Cancer Research. According to data from OpenAlex, Behnaz Lahooti has authored 11 papers receiving a total of 470 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 3 papers in Biomaterials and 3 papers in Cancer Research. Recurrent topics in Behnaz Lahooti's work include Angiogenesis and VEGF in Cancer (3 papers), MicroRNA in disease regulation (2 papers) and Nanoparticle-Based Drug Delivery (2 papers). Behnaz Lahooti is often cited by papers focused on Angiogenesis and VEGF in Cancer (3 papers), MicroRNA in disease regulation (2 papers) and Nanoparticle-Based Drug Delivery (2 papers). Behnaz Lahooti collaborates with scholars based in United States, Greece and India. Behnaz Lahooti's co-authors include Tanya Chhibber, Sounak Bagchi, Rahul Dev Jayant, Angela Verma, Vivek Borse, George Mattheolabakis, Constantinos M. Mikelis, Ahmed Alobaida, Μαργαρίτα Λάμπρου and Racheal G. Akwii and has published in prestigious journals such as International Journal of Molecular Sciences, Journal of Controlled Release and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

Behnaz Lahooti

10 papers receiving 467 citations

Peers

Behnaz Lahooti

MB

BE

NEURO

BIOMA

ONCOL

Tanya Chhibber United States

Tingfang Wang China

Baoan Chen China

Jianping Zhu China

Guoliang Xiong China

Romain Brusini France

Nathan B. Roberts United States

Juan Aparicio-Blanco Spain

Manal Alaamery Saudi Arabia

Przemysław Wielgat Poland

Tanya Chhibber United States

Behnaz Lahooti

184 ×1.0

MB

211 ×1.5

BE

92 ×1.0

NEURO

59 ×0.7

BIOMA

82 ×1.5

ONCOL

Citations per year, relative to Behnaz Lahooti Behnaz Lahooti (= 1×) peers Tanya Chhibber

Countries citing papers authored by Behnaz Lahooti

Since Specialization

Citations

This map shows the geographic impact of Behnaz Lahooti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Behnaz Lahooti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Behnaz Lahooti more than expected).

Fields of papers citing papers by Behnaz Lahooti

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Behnaz Lahooti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Behnaz Lahooti. The network helps show where Behnaz Lahooti may publish in the future.

Co-authorship network of co-authors of Behnaz Lahooti

This figure shows the co-authorship network connecting the top 25 collaborators of Behnaz Lahooti. A scholar is included among the top collaborators of Behnaz Lahooti based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Behnaz Lahooti. Behnaz Lahooti is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

1.

Lahooti, Behnaz, et al.. (2024). Stable Dual miR-143 and miR-506 Upregulation Inhibits Proliferation and Cell Cycle Progression. International Journal of Molecular Sciences. 25(8). 4432–4432.

2.

Lahooti, Behnaz, Racheal G. Akwii, Fatema Tuz Zahra, et al.. (2023). Targeting endothelial permeability in the EPR effect. Journal of Controlled Release. 361. 212–235. 66 indexed citations

3.

Lahooti, Behnaz, Racheal G. Akwii, Dhaval Patel, et al.. (2023). Endothelial-Specific Targeting of RhoA Signaling via CD31 Antibody-Conjugated Nanoparticles. Journal of Pharmacology and Experimental Therapeutics. 385(1). 35–49. 6 indexed citations

4.

Lahooti, Behnaz, et al.. (2022). Chlorotoxin and Lung Cancer: A Targeting Perspective for Drug Delivery. Pharmaceutics. 14(12). 2613–2613. 3 indexed citations

5.

Lahooti, Behnaz, Sounak Bagchi, Tanya Chhibber, et al.. (2021). Nanomedicine for the SARS-CoV-2: State-of-the-Art and Future Prospects. International Journal of Nanomedicine. Volume 16. 539–560. 67 indexed citations

6.

Lahooti, Behnaz, et al.. (2021). MiRNAs as Anti-Angiogenic Adjuvant Therapy in Cancer: Synopsis and Potential. Frontiers in Oncology. 11. 705634–705634. 10 indexed citations

7.

Al‐Hilal, Taslim A., Ali Keshavarz, Hossam Kadry, et al.. (2020). Pulmonary-arterial-hypertension (PAH)-on-a-chip: fabrication, validation and application. Lab on a Chip. 20(18). 3334–3345. 28 indexed citations

8.

Lahooti, Behnaz, et al.. (2020). Therapeutic role of inflammasome inhibitors in neurodegenerative disorders. Brain Behavior and Immunity. 91. 771–783. 39 indexed citations

9.

Bagchi, Sounak, Tanya Chhibber, Behnaz Lahooti, et al.. (2019). <p>In-vitro blood-brain barrier models for drug screening and permeation studies: an overview</p>. Drug Design Development and Therapy. Volume 13. 3591–3605. 175 indexed citations

10.

Chhibber, Tanya, Sounak Bagchi, Behnaz Lahooti, et al.. (2019). CNS organoids: an innovative tool for neurological disease modeling and drug neurotoxicity screening. Drug Discovery Today. 25(2). 456–465. 47 indexed citations

11.

Lahooti, Behnaz, Mohammad Khorram, Gholamreza Karimi, Aliakbar Mohammadi, & Amir Emami. (2016). Modeling and optimization of antibacterial activity of the chitosan‐based hydrogel films using central composite design. Journal of Biomedical Materials Research Part A. 104(10). 2544–2553. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact